The prescription drug Ketek is an antibiotic manufactured by Sanofi-Aventis. On February 17, 2007, the FDA ordered the manufacturer of Ketek to include a so-called black box warning for doctors and patients, outlining liver problems associated with Ketek. Ketek has been used for a number of infections, including acute bacterial sinusitis and acute bacterial exacerbations of chronic bronchitis. The black box warning is designed to ensure that Ketek is only used to treat pneumonia, because of the potential damage caused by this pharmaceutical. Further, the black box warns against use in patients with myasthenia gravis.

Numerous observers have questioned how the FDA approved the use of Ketek in 2004, and what damage may have been caused to the estimated 5.6 million people that have taken the drug since that time. If you believe that Ketek use may have put you in danger, please contact us through this website to obtain a free consultation and learn more.